Pingli Wang

1.6k total citations
63 papers, 1.1k citations indexed

About

Pingli Wang is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Pingli Wang has authored 63 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Pulmonary and Respiratory Medicine, 21 papers in Oncology and 13 papers in Molecular Biology. Recurrent topics in Pingli Wang's work include Lung Cancer Treatments and Mutations (19 papers), Cancer Immunotherapy and Biomarkers (9 papers) and Lung Cancer Research Studies (9 papers). Pingli Wang is often cited by papers focused on Lung Cancer Treatments and Mutations (19 papers), Cancer Immunotherapy and Biomarkers (9 papers) and Lung Cancer Research Studies (9 papers). Pingli Wang collaborates with scholars based in China, United States and Japan. Pingli Wang's co-authors include Kiyoshi Ohura, Kai Wang, Ying Yang, Shoujie Chai, Stephania A. Cormier, Yiming Yang, Xia Xu, Chenchen Zhang, Jordy Saravia and Chengyan Zhang and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Small.

In The Last Decade

Pingli Wang

56 papers receiving 1.1k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Pingli Wang 363 285 235 212 211 63 1.1k
Cheng Pan 727 2.0× 470 1.6× 305 1.3× 193 0.9× 167 0.8× 71 1.6k
Vincent Yeung 497 1.4× 113 0.4× 100 0.4× 140 0.7× 184 0.9× 35 894
Xiaoshuang Wang 384 1.1× 157 0.6× 184 0.8× 158 0.7× 103 0.5× 40 1.0k
Dario Arzani 433 1.2× 283 1.0× 77 0.3× 174 0.8× 190 0.9× 51 1.2k
Gwo‐Shing Chen 289 0.8× 304 1.1× 344 1.5× 96 0.5× 83 0.4× 74 1.6k
Xiaoyue Jia 483 1.3× 158 0.6× 51 0.2× 84 0.4× 133 0.6× 32 810
Jau-Yi Li 613 1.7× 168 0.6× 176 0.7× 104 0.5× 63 0.3× 8 1.3k
Lisong Lin 302 0.8× 273 1.0× 29 0.1× 133 0.6× 225 1.1× 91 1.0k
Yashodhar P. Bhandary 461 1.3× 114 0.4× 184 0.8× 608 2.9× 235 1.1× 66 1.3k
Erna Snellman 390 1.1× 333 1.2× 438 1.9× 163 0.8× 170 0.8× 73 1.6k

Countries citing papers authored by Pingli Wang

Since Specialization
Citations

This map shows the geographic impact of Pingli Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pingli Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pingli Wang more than expected).

Fields of papers citing papers by Pingli Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pingli Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pingli Wang. The network helps show where Pingli Wang may publish in the future.

Co-authorship network of co-authors of Pingli Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Pingli Wang. A scholar is included among the top collaborators of Pingli Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pingli Wang. Pingli Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lin, Jun, et al.. (2025). CD34 evaluation of microvasculature in lung adenocarcinoma and its microvascular density predicts postoperative tumor recurrence. Pathology & Oncology Research. 31. 1611985–1611985. 1 indexed citations
2.
Li, Hongxuan, et al.. (2025). Development and identification of porcine monoclonal antibodies against PEDV from single B cells. Veterinary Immunology and Immunopathology. 285. 110951–110951. 1 indexed citations
3.
Jiao, Yurong, Xiangxing Kong, Yuehua Han, et al.. (2025). DNA remnants in red blood cells enable early detection of cancer. Cell Research. 35(8). 568–587.
4.
Ding, Liang, Pingli Wang, Jianzhen Shan, et al.. (2024). EP.08D.09 Efficacy and Safety of Neoadjuvant Tislelizumab Plus Chemotherapy for the Treatment of Non-Small Cell Lung Cancer: a Pooled Analysis. Journal of Thoracic Oncology. 19(10). S571–S572.
5.
Xu, Zhiyong, Zhiyong Xu, Yueli Shi, et al.. (2024). Novel SERCA2 inhibitor Diphyllin displays anti-tumor effect in non-small cell lung cancer by promoting endoplasmic reticulum stress and mitochondrial dysfunction. Cancer Letters. 598. 217075–217075. 9 indexed citations
6.
Zhang, Chengyan, Bei Zhang, Zhengbo Song, et al.. (2024). Blockade of CD93 in pleural mesothelial cells fuels anti-lung tumor immune responses. Theranostics. 14(3). 1010–1028. 4 indexed citations
7.
Shi, Yuankai, Xingsheng Hu, Xingya Li, et al.. (2024). Ficonalkib (SY-3505) in Advanced ALK-Positive NSCLC: A Multicenter, Open-Label, Single-Arm, Phase 1/2 Study. Journal of Thoracic Oncology. 19(6). 898–911.
8.
Lin, Jun, et al.. (2024). Characteristics of mast cell infiltration in lung adenocarcinoma and its impact on prognosis. Discover Oncology. 15(1). 208–208. 1 indexed citations
9.
10.
Huang, Xiaojie, et al.. (2022). Case Report: Short-Term Response to First-Line Crizotinib Monotherapy in a Metastatic Lung Adenocarcinoma Patient Harboring a Novel TPR-ROS1 Fusion. Frontiers in Oncology. 12. 862008–862008. 2 indexed citations
11.
Li, Shumin, et al.. (2020). Emerging Blood-Based Biomarkers for Predicting Response to Checkpoint Immunotherapy in Non-Small-Cell Lung Cancer. Frontiers in Immunology. 11. 603157–603157. 30 indexed citations
12.
Jaligama, Sridhar, Vivek Patel, Pingli Wang, et al.. (2018). Radical containing combustion derived particulate matter enhance pulmonary Th17 inflammation via the aryl hydrocarbon receptor. Particle and Fibre Toxicology. 15(1). 20–20. 36 indexed citations
13.
Wang, Pingli, Chengyan Zhang, Juan Yu, et al.. (2017). Clinical profiles and trend analysis of newly diagnosed lung cancer in a tertiary care hospital of East China during 2011–2015. Journal of Thoracic Disease. 9(7). 1973–1979. 10 indexed citations
14.
Wang, Pingli, et al.. (2017). Acute Disseminated Talaromyces marneffei in An Immunocompetent Patient. Mycopathologia. 182(7-8). 751–754. 14 indexed citations
15.
Yang, Yan, Liren Ding, & Pingli Wang. (2016). Dramatic response to anti-PD-1 therapy in a patient of squamous cell carcinoma of thymus with multiple lung metastases. Journal of Thoracic Disease. 8(7). E535–E537. 17 indexed citations
16.
Xu, Xia, Shoujie Chai, Pingli Wang, et al.. (2015). Aldehyde dehydrogenases and cancer stem cells. Cancer Letters. 369(1). 50–57. 160 indexed citations
17.
Wang, Pingli, et al.. (2011). Radical-Containing Particles Activate Dendritic Cells and Enhance Th17 Inflammation in a Mouse Model of Asthma. American Journal of Respiratory Cell and Molecular Biology. 45(5). 977–983. 62 indexed citations
18.
Wang, Pingli, Gensheng Zhang, Xuejun Qin, et al.. (2011). Inhibition of allergen-induced airway remodeling by neonatal bacillus Calmette-Guerin vaccination is associated with interferon-gamma–producing T cells but not regulatory T cells in mice. Annals of Allergy Asthma & Immunology. 107(2). 163–170. 10 indexed citations
19.
Wang, Pingli, Gensheng Zhang, & Huahao Shen. (2009). Multiple synchronous primary malignancies induced by benzene exposure: a case report. Journal of Occupational Medicine and Toxicology. 4(1). 7–7. 2 indexed citations
20.
Wang, Pingli, et al.. (1993). New Taxa of Heracleum L. (Umbelliferae) from China. Journal of Systematics and Evolution. 31(4). 368–373. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cheng Pan Breakdown of academic impact, for papers by Vincent Yeung Breakdown of academic impact, for papers by Xiaoshuang Wang Breakdown of academic impact, for papers by Dario Arzani Breakdown of academic impact, for papers by Gwo‐Shing Chen Breakdown of academic impact, for papers by Xiaoyue Jia Breakdown of academic impact, for papers by Jau-Yi Li Breakdown of academic impact, for papers by Lisong Lin Breakdown of academic impact, for papers by Yashodhar P. Bhandary Breakdown of academic impact, for papers by Erna Snellman
Rankless by CCL
2026